LifeMD Files 8-K: Regulation FD & Financials

Ticker: LFMDP · Form: 8-K · Filed: Apr 29, 2025 · CIK: 948320

Lifemd, INC. 8-K Filing Summary
FieldDetail
CompanyLifemd, INC. (LFMDP)
Form Type8-K
Filed DateApr 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financials

Related Tickers: LFMD

TL;DR

LifeMD dropped an 8-K on Friday covering Reg FD and financials. Check it out.

AI Summary

LifeMD, Inc. filed an 8-K on April 29, 2025, reporting events as of April 25, 2025. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. The company, formerly known as Conversion Labs, Inc. and Immudyne, Inc., is incorporated in Delaware and headquartered in New York.

Why It Matters

This 8-K filing provides important updates on LifeMD's regulatory compliance and financial reporting, which are crucial for investors to assess the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of information and does not appear to contain any immediate negative news or significant changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for LifeMD, Inc.?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to include financial statements and exhibits.

What is the earliest event date reported in this filing?

The earliest event date reported in this filing is April 25, 2025.

When was LifeMD, Inc. incorporated?

LifeMD, Inc. was incorporated in Delaware.

What were some of LifeMD, Inc.'s former company names?

LifeMD, Inc. was formerly known as Conversion Labs, Inc. and Immudyne, Inc.

What is LifeMD, Inc.'s business address?

LifeMD, Inc.'s business address is 236 Fifth Avenue, Suite 400, New York, NY 10001.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding LifeMD, Inc. (LFMDP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing